Phosphatidylinositol 3-kinase in breast cancer: where from here?
Paradiso
Angelo
A
Clinical Experimental Oncology Laboratory, National Cancer Institute, Bari, Italy. a.paradiso@oncologico.bari.it
Angelo
Paradiso
P
Mangia
Anita
A
Anita
Mangia
M
Azzariti
Amalia
A
Amalia
Azzarit
A
Tommasi
Stefania
S
Stefania
Tommasi
T
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D001943:Breast Neoplasms / Q000201:enzymology* / Q000473:pathology*; D019281:Dimerization; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005091:Exons; D006801:Humans; D008954:Models, Biological; D009154:Mutation; D009687:Nuclear Proteins / Q000378:metabolism; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism / Q000502:physiology*; D015398:Signal Transduction; D014157:Transcription Factors / Q000378:metabolism
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D009687:Nuclear Proteins; C503859:PI3KCA protein, human; D014157:Transcription Factors; D019869:Phosphatidylinositol 3-Kinases